Nervgen Pharma Corp.

NGEN

As of the close on Sep 25, 2026

Price

$1.94

Market cap

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

P/E (diluted TTM)

—

The last four quarters are not all on file

EPS (TTM)

—

The last four quarters are not all on file

Dividend yield

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Nervgen Pharma Corp. Makes Money

No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 2 annual periods. The latest annual period ends Dec 31, 2025.

Ownership

Ownership filing history is not available for this company.